BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2832120)

  • 1. Plasma levels of main granulocyte components during hemodialysis.
    Hörl WH; Riegel W; Steinhauer HB; Wanner C; Schollmeyer P; Schaefer RM; Heidland A
    Contrib Nephrol; 1987; 59():35-43. PubMed ID: 2832120
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes.
    Hörl WH; Riegel W; Schollmeyer P
    Nephron; 1987; 45(4):272-6. PubMed ID: 3035392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
    Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
    Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of main granulocyte components during hemodialysis: effects of immunosuppression.
    Riegel W; Leverenz K; Schollmeyer P; Wilms H; Hörl WH
    Nephron; 1987; 46(2):161-6. PubMed ID: 3037400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced plasma and intracellular levels of main granulocyte components in diabetics on dialysis.
    Hörl WH; Schaefer RM; Wanner C; Bahlmann J; Reitinger J; Schollmeyer P; Heidland A
    Blood Purif; 1989; 7(6):314-23. PubMed ID: 2482056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of main granulocyte components during cardiopulmonary bypass.
    Riegel W; Spillner G; Schlosser V; Hörl WH
    J Thorac Cardiovasc Surg; 1988 Jun; 95(6):1014-9. PubMed ID: 2836662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes.
    Hörl WH; Steinhauer HB; Schollmeyer P
    Kidney Int; 1985 Nov; 28(5):791-6. PubMed ID: 3878906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-2-microglobulin and main granulocyte components in hemodialysis patients.
    Haag-Weber M; Schollmeyer P; Hörl WH
    Artif Organs; 1989 Apr; 13(2):92-6. PubMed ID: 2650660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of degranulation of polymorphonuclear leukocytes by immunosuppression in patients following cadaveric renal transplantation.
    Hörl WH; Wanner C; Riegel W; Schlosser W; Wilms H; Schollmeyer P
    Transplantation; 1989 Jan; 47(1):144-8. PubMed ID: 2536200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of main granulocyte components during hemodialysis. Comparison of new and reused dialyzers.
    Hörl WH; Feinstein EI; Wanner C; Frischmuth N; Gösele A; Massry SG
    Am J Nephrol; 1990; 10(1):53-7. PubMed ID: 2343881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
    Schaefer RM; Hörl WH; Kokot K; Heidland A
    Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anticoagulation on plasma levels of granulocyte elastase during hemodialysis.
    Bonal J; Romero R; Pastor MC; Teixidó J; Caralps A
    Am J Nephrol; 1986; 6(6):487. PubMed ID: 3645955
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of different dialyzers on proteinases and proteinase inhibitors during hemodialysis.
    Hörl WH; Schaefer RM; Heidland A
    Am J Nephrol; 1985; 5(5):320-6. PubMed ID: 2414989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockers.
    Haag-Weber M; Schollmeyer P; Hörl WH
    Eur J Clin Invest; 1988 Aug; 18(4):380-5. PubMed ID: 3139423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dialyzer geometry on granulocyte and complement activation.
    Schaefer RM; Heidland A; Hörl WH
    Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
    Nuijens JH; Abbink JJ; Wachtfogel YT; Colman RW; Eerenberg AJ; Dors D; Kamp AJ; Strack van Schijndel RJ; Thijs LG; Hack CE
    J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of immunosuppression on the release of main granulocyte components: in vivo and in vitro studies.
    Wanner C; Simon B; Gösele A; Riegel W; Schollmeyer P; Hörl WH
    Adv Exp Med Biol; 1988; 240():385-9. PubMed ID: 2854360
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of blood sampling techniques on plasma concentrations of lactoferrin and elastase-alpha 1-PI.
    Maacks S; Tegtmeyer KF; Wood WG
    Ann Clin Biochem; 1990 Sep; 27 ( Pt 5)():512-3. PubMed ID: 2281936
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of cuprophan, hemophan and polysulfone membranes on the oxidative metabolism, degranulation reaction, enzyme release and pulmonary sequestration of granulocytes.
    Kolb G; Fischer W; Schoenemann H; Bathke K; Höffken H; Müller T; Lange H; Joseph K; Havemann K
    Contrib Nephrol; 1989; 74():10-21. PubMed ID: 2562018
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of dialyzer compatibility by reduction of membrane surface area.
    Schaefer RM; Rautenberg W; Neumann S; Heidland A; Hörl WH
    Clin Nephrol; 1986; 26 Suppl 1():S35-8. PubMed ID: 3644705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.